A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)
Bailey CJ, Flatt PR, Conlon JM
Note whether the color has changed since your last dose from this same vial
As these factors are managed, a healthcare provider can help determine whether continuing, adjusting, or eventually discontinuing medication makes sense
Potes, C
For GLP-1 users who find that their appetite comes and goes unpredictably, having a recipe this fast in your back pocket is a game-changer